1. A series of linear pulse experiments were carried out at different flowrates in the FDA’s Policy Statement for the Development of New Stereo Isomeric Drugs, 417 US Food and Drug Administration. Federal Regulations 22 (1992).
2. FDA, Guidance for Industry: PAT – A Framework for Innovative Pharmaceutical Development, Manufacturing and Quality Assurance (2004).
3. Simulated moving bed chromatography for the separation of enantiomers;Rajendran;J. Chromatogr. A,2009
4. H.S. Traub, Preparative Chromatography, Weinheim, Germany (2005).
5. R.M. Nicoud, Chromatographic Processes: Modeling, Simulation and Design, Cambridge University Press, United Kingdom (2015).